September 02, 2025

New Bruton’s Tyrosine Kinase Inhibitor Improves Platelet Response

The FDA has approved rilzabrutinib (Wayrilz) as the first Bruton’s tyrosine kinase inhibitor for adults with chronic or persistent immune thrombocytopenia who have had an insufficient response to prior therapy.

Conexiant

September 02, 2025

Pediatric Sepsis Outcomes by EBV Serostatus

Patients who were Epstein-Barr virus seropositive showed higher levels of immune dysregulation markers.

Conexiant

September 02, 2025

Can AI Reliably Detect Periodontal Disease From Photos?

Artificial intelligence models are being tested for periodontal disease detection using intraoral photographs, but external validation shows performance often declines across populations and imaging devices.

Conexiant

September 02, 2025

Protocol Enhancements for Biomarkers, Neoadjuvant Therapy, and AI

Updates aim to improve clarity and consistency in pathology reporting amid growing demands from clinical oncology

The Pathologist

September 02, 2025

ctDNA outperforms PET/CT for Remission Assessment 

Study evaluates ctDNA for measurable residual disease testing in large B-cell lymphoma

The Pathologist

September 01, 2025

Keloid Scar Pathogenesis: New Insights

Elevated PIEZO2 in keloid fibroblasts and endothelial cells correlates with collagen pathways and recurrence

The Pathologist

September 01, 2025

Breaking Silos, Building Futures

Meaningful interactions, shared challenges, and collaboration take center stage at the ASCP Annual Meeting

The Pathologist

August 29, 2025

Machine Learning Predicts Rare Blood Cancer

Researchers used complete blood counts parameters to accurately predict polycythemia vera

The Pathologist

August 29, 2025

Report and Reflect: Communicating to a Crowd

Bethany Williams shares her top tips for scientific event management

The Pathologist